Russia vs Tanzania: The number of people with susceptibility test result for rifampicin
Russia
21,391
in 2021
Tanzania
26,624
in 2021
Russia rank
15th
Tanzania rank
12th
The number of people with susceptibility test result for rifampicin over time
- Russia
- Tanzania
How they compare
Tanzania currently reports 26,624 against 21,391 in Russia, a difference of 5,233.
That makes Tanzania's figure about 1.2 times Russia's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Russia ahead.
Russia ranks 15th and Tanzania ranks 12th of 155 countries.
Across the 2 decades both report, Russia averaged higher in 1 and Tanzania in 1.
Head to head by decade
| Decade | Russia | Tanzania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 27,743 | 16,817 | 10,927 | Russia |
| 2020s | 21,245 | 22,648 | 1,404 | Tanzania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Russia or Tanzania?
- Tanzania, at 26,624 against 21,391 in Russia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Russia and Tanzania?
- 5,233, with Tanzania ahead.
- How many years of comparable data are there for Russia and Tanzania?
- 5 years are reported by both, from 2017 to 2021.
- How do Russia and Tanzania rank globally for the number of people with susceptibility test result for rifampicin?
- Russia ranks 15th and Tanzania ranks 12th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.